Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

LC-MS/MS Hormone Detection and Analysis: Technical Principles, Methods, and Applications

LC-MS/MS hormone detection analysis is the gold-standard analytical platform for the accurate identification and quantification of steroid, thyroid, and anabolic hormones at trace levels in clinical, food, and environmental matrices. By coupling high-performance liquid chromatography separation with tandem mass spectrometry detection, this technology delivers exceptional specificity, multiplexing capability, and detection limits down to the picogram-per-milliliter range. This article provides a comprehensive overview of LC-MS/MS hormone testing, covering sample types, target analytes, method workflows, validation requirements, and practical applications.

Technical Overview

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) combines the high-resolution separation power of liquid chromatography with the sensitive, selective detection capability of tandem mass spectrometry. In hormone analysis, the chromatographic system first separates individual hormone analytes from complex biological, food, or environmental matrices. The eluted compounds are then ionized, typically by electrospray ionization (ESI) or atmospheric pressure chemical ionization (APCI), and analyzed by a triple quadrupole mass spectrometer operating in multiple reaction monitoring (MRM) mode.

Hormones present unique analytical challenges: they occur at extremely low concentrations (often pg/mL to low ng/mL), include many structurally similar isobaric compounds, and are susceptible to matrix effects from lipids, proteins, and salts. LC-MS/MS addresses these challenges by monitoring two characteristic precursor-to-product ion transitions per analyte, one for quantification and one for confirmation, which provides a level of structural specificity that immunoassays cannot match due to antibody cross-reactivity.

Compared with conventional immunoassay platforms, LC-MS/MS hormone testing offers several decisive advantages: simultaneous quantification of multiple hormones in a single injection, wider linear dynamic range, superior analytical specificity, smaller sample volume requirements, and lower long-term reagent costs. These capabilities have made LC-MS/MS the reference method in clinical endocrinology, sports anti-doping control, veterinary residue surveillance, and environmental endocrine disruptor monitoring.

Testing Samples

Clinical and Biological Samples

Clinical specimens represent the largest application area for LC-MS/MS hormone testing. Acceptable sample types include human serum, plasma, random and 24-hour urine, saliva, amniotic fluid, cerebrospinal fluid, and dried blood spots used in newborn screening programs. Serum and plasma samples are typically collected in plain or heparinized tubes, with EDTA plasma preferred for certain peptide-related assays to minimize ex vivo degradation. Proper collection timing is critical for hormones with strong circadian rhythms, such as cortisol and testosterone.

Food and Agricultural Samples

For food safety surveillance, LC-MS/MS hormone analysis is performed on foodstuffs of animal origin, including bovine, porcine, ovine, and poultry muscle tissue, liver and kidney samples, raw milk and dairy products, eggs, honey, and aquatic products. Animal feed and premix samples are also tested for the illegal incorporation of anabolic agents and growth-promoting hormones. These matrices require more extensive extraction and cleanup due to high lipid and protein content.

Environmental Samples

Natural and synthetic hormones enter the environment through municipal wastewater discharge, livestock farming runoff, and landfill leachate. LC-MS/MS testing is conducted on surface water, groundwater, wastewater treatment plant influent and effluent, as well as soil and sediment samples to monitor endocrine-disrupting compounds at ng/L concentrations.

Pharmaceutical and Cosmetic Samples

Hormone-containing pharmaceutical formulations, active pharmaceutical ingredients, raw materials, and cosmetic products are analyzed to verify label-claimed hormone content, detect undeclared hormonal additives, and support stability studies and bioequivalence testing.

Testing Items

LC-MS/MS hormone panels are highly customizable and can quantify dozens of analytes simultaneously. Typical testing items include:

  • Glucocorticoids: cortisol, cortisone, corticosterone, 11-deoxycortisol, prednisolone, prednisone, dexamethasone, and betamethasone
  • Mineralocorticoids: aldosterone, 11-deoxycorticosterone, and 18-hydroxycorticosterone
  • Androgens: testosterone, dihydrotestosterone, androstenedione, dehydroepiandrosterone (DHEA), and DHEA sulfate
  • Estrogens: estrone (E1), 17-beta-estradiol (E2), estriol (E3), and ethinyl estradiol
  • Progestogens: progesterone, 17-hydroxyprogesterone, and synthetic progestins such as norethisterone and medroxyprogesterone
  • Thyroid hormones: triiodothyronine (T3), thyroxine (T4), and reverse T3 (rT3)
  • Anabolic agents and growth promoters: nandrolone, stanozolol, trenbolone, boldenone, zeranol and its metabolites, melengestrol acetate, and selected beta-agonists co-monitored in residue programs
  • Precursor and intermediate steroids: pregnenolone, 17-hydroxypregnenolone, and 11-deoxycortisol for comprehensive steroid profiling

Comprehensive steroid profiling panels covering more than 15 analytes in a single run are widely used in clinical endocrinology, enabling differential diagnosis through analyte ratio interpretation rather than single-marker measurement.

Testing Methods

Sample Preparation

Sample preparation is the most critical determinant of method performance. Common workflows include protein precipitation for high-abundance clinical analytes, liquid-liquid extraction (LLE) for steroid enrichment, and solid-phase extraction (SPE) using polymeric reversed-phase or mixed-mode sorbents for maximum cleanup and concentration. Food and feed matrices typically require homogenization, enzymatic hydrolysis of conjugated hormones, n-hexane defatting, and SPE cleanup. Chemical derivatization, for example with dansyl chloride for estrogens, is employed to enhance ionization efficiency for poorly ionizing analytes and achieve sub-pg/mL detection limits. Isotopically labeled internal standards (deuterated or carbon-13 analogues) are added at the earliest possible step to correct for extraction losses and matrix-induced ion suppression.

Chromatographic Separation

Reversed-phase UHPLC using C18 or phenyl-hexyl columns is the standard configuration, with water and methanol or acetonitrile mobile phases buffered with ammonium fluoride, ammonium formate, or ammonium acetate. Chromatographic resolution is essential for separating isobaric steroid pairs that share identical mass transitions, such as cortisol and prednisolone, or corticosterone and 11-deoxycortisol. Typical run times range from 5 to 15 minutes per injection, depending on panel complexity.

Mass Spectrometric Detection

Most steroid hormones are detected in positive ESI mode using MRM transitions optimized by direct infusion of pure standards. Estrogens are traditionally analyzed in negative ESI mode or after derivatization in positive mode. APCI serves as an alternative for less polar steroids with poor ESI response. Each analyte is monitored with at least two transitions: a quantifier transition for measurement and a qualifier transition for identity confirmation, with retention time and ion ratio criteria applied in accordance with internationally recognized identification point systems.

Quantification and Calibration

Quantification is performed using isotope-dilution calibration curves constructed with matrix-matched calibrators spanning the expected concentration range, typically with 1/x or 1/x squared weighted linear regression achieving a coefficient of determination of 0.99 or better. Calibrator and control materials traceable to certified reference materials are used wherever available to ensure metrological traceability of reported results.

Method Validation and Quality Assurance

Methods are validated under the frameworks of ISO/IEC 17025 for testing laboratories, ISO 15189 for medical laboratories, and CLSI C62-A guidance for LC-MS/MS methods, with additional reference to recognized bioanalytical method validation guidelines from drug regulatory authorities. Key validation parameters include selectivity, carryover, linearity, intra-day and inter-day precision (CV typically within 15 percent), accuracy or trueness (typically 85 to 115 percent of nominal concentration), limit of detection, limit of quantification, extraction recovery, matrix effect, and analyte stability under handling and storage conditions. Routine quality control incorporates reagent blanks, matrix blanks, calibration verification standards, two-level QC samples in each batch, duplicate analysis, and periodic participation in proficiency testing schemes organized by accredited providers.

Applications

LC-MS/MS hormone detection supports decision-making across clinical, regulatory, industrial, and research domains:

  • Clinical endocrinology: diagnosis and monitoring of congenital adrenal hyperplasia through newborn screening, evaluation of polycystic ovary syndrome, Cushing syndrome and Addison disease workups, male and female infertility assessment, delayed puberty evaluation, and thyroid function testing
  • Therapeutic drug monitoring: quantification of glucocorticoid replacement and suppression therapy to guide individualized dosing
  • Sports anti-doping: detection of exogenous anabolic steroids and synthetic hormones in athlete urine and blood samples in accordance with World Anti-Doping Agency technical documents
  • Food safety surveillance: national residue monitoring plans screening foodstuffs of animal origin for banned anabolic agents and growth promoters under frameworks such as GB/T 21981 and relevant EU regulations on pharmacologically active substances in animal-derived foods
  • Environmental monitoring: tracking natural and synthetic estrogens and androgens in water bodies to assess endocrine-disrupting risk to aquatic ecosystems
  • Pharmaceutical and cosmetic industry: quality control of hormone formulations, detection of undeclared hormone additives in cosmetics, and support for bioavailability and bioequivalence studies
  • Academic and epidemiological research: large-cohort hormone biomarker studies in oncology, metabolic disease, reproductive health, and exposome research

FAQ

Why is LC-MS/MS preferred over immunoassay for hormone testing?

LC-MS/MS eliminates the antibody cross-reactivity problems that affect immunoassays, provides direct structural confirmation through mass transitions, quantifies multiple hormones simultaneously in one run, and maintains accuracy at very low concentrations. This is particularly important for analytes such as estradiol in children and men, where immunoassays often lack adequate sensitivity and specificity.

What sample volume is required for analysis?

Modern LC-MS/MS methods typically require only 50 to 200 microliters of serum, plasma, or urine for a comprehensive steroid panel, and dried blood spot methods can work with just a few microliters, which is especially valuable for pediatric and newborn screening applications.

What detection limits can be achieved?

Standard methods achieve limits of quantification in the range of 0.01 to 1 ng/mL for most steroid hormones. With derivatization and highly sensitive instrumentation, estradiol can be reliably quantified below 5 pg/mL, meeting the most demanding clinical requirements.

Which standards and regulations govern LC-MS/MS hormone testing?

Laboratory competence is governed by ISO/IEC 17025 and ISO 15189, method development follows CLSI C62-A and recognized bioanalytical validation guidance, food residue testing references national standards such as GB/T 21981 and applicable EU regulations, and sports testing follows World Anti-Doping Agency technical documents. Accredited third-party laboratories conduct testing under these frameworks.

How are matrix effects controlled in routine analysis?

Matrix effects are controlled through a combination of effective sample cleanup, isotopically labeled internal standards added before extraction, matrix-matched calibration, post-column infusion assessment during method development, and acceptance criteria for internal standard response in each batch.

What is the typical turnaround time?

Once samples are received, routine clinical hormone panels are typically completed within 3 to 7 working days, while complex multi-residue food testing programs may require 7 to 10 working days depending on the scope, sample load, and confirmation requirements.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing